China National Medicines Corporation Ltd. (SHA:600511)
China flag China · Delayed Price · Currency is CNY
28.70
-0.08 (-0.28%)
Mar 26, 2026, 2:04 PM CST

SHA:600511 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
52,46850,50049,59245,43646,442
Other Revenue
-97.79103.9962.9526.26
52,46850,59749,69645,49946,469
Revenue Growth (YoY)
3.70%1.81%9.22%-2.09%15.08%
Cost of Revenue
49,00847,00345,70441,68142,848
Gross Profit
3,4603,5943,9923,8173,621
Selling, General & Admin
1,1901,2671,4301,3921,355
Research & Development
69.3173.7171.26755.75
Other Operating Expenses
128.16126.25109.6946.91120.86
Operating Expenses
1,3871,4891,6201,4981,566
Operating Income
2,0722,1052,3722,3192,055
Interest Expense
--33.66-31.57-26.88-43.71
Interest & Investment Income
566.78620.95525.32362.42354.09
Currency Exchange Gain (Loss)
-1.940.55-1.652.71
Other Non Operating Income (Expenses)
-33.74-7.04-9.23-43.29-18
EBT Excluding Unusual Items
2,6052,6872,8572,6092,350
Gain (Loss) on Sale of Investments
0.07-18.210.82--
Gain (Loss) on Sale of Assets
0.21-0.190.081.68-0.07
Asset Writedown
-5.56----
Other Unusual Items
--14.962.8176.995.08
Pretax Income
2,6002,6542,9312,6882,445
Income Tax Expense
510.74523.83596.42559.18516.3
Earnings From Continuing Operations
2,0892,1302,3342,1291,929
Minority Interest in Earnings
-92.81-129.65-188.47-164.65-174.42
Net Income
1,9972,0002,1461,9641,754
Net Income to Common
1,9972,0002,1461,9641,754
Net Income Growth
-0.18%-6.80%9.26%11.97%26.86%
Shares Outstanding (Basic)
755755754755755
Shares Outstanding (Diluted)
755755754755755
Shares Change (YoY)
0.00%0.00%-0.00%-0.00%
EPS (Basic)
2.652.652.842.602.32
EPS (Diluted)
2.652.652.842.602.32
EPS Growth
-0.18%-6.80%9.27%11.97%26.86%
Free Cash Flow
1,9371,5282,5822,2651,862
Free Cash Flow Per Share
2.572.033.423.002.47
Dividend Per Share
-0.8000.8540.7820.700
Dividend Growth
--6.32%9.21%11.71%27.27%
Gross Margin
6.59%7.10%8.03%8.39%7.79%
Operating Margin
3.95%4.16%4.77%5.10%4.42%
Profit Margin
3.81%3.95%4.32%4.32%3.77%
Free Cash Flow Margin
3.69%3.02%5.20%4.98%4.01%
EBITDA
2,2002,2152,4852,4232,155
EBITDA Margin
4.19%4.38%5.00%5.32%4.64%
D&A For EBITDA
127.66110.03113.09103.86100.1
EBIT
2,0722,1052,3722,3192,055
EBIT Margin
3.95%4.16%4.77%5.10%4.42%
Effective Tax Rate
19.64%19.74%20.35%20.80%21.12%
Revenue as Reported
-50,59749,69645,49946,469
Advertising Expenses
-4.746.73.252.25
Source: S&P Global Market Intelligence. Standard template. Financial Sources.